Aardvark Therapeutics (AARD) Enterprise Value (2024 - 2026)
Aardvark Therapeutics (AARD) reported Enterprise Value of -$120.0 million for Q1 2026, up 56.54% on a YoY basis from -$76.6 million in Q1 2025, and down 9.03% sequentially from -$110.0 million in Q4 2025.
Aardvark Therapeutics (AARD) Enterprise Value (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Enterprise Value data on file, last reported at -$120.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 56.54% year-over-year to -$120.0 million; the trailing twelve-month figure through Mar 2026 stood at -$120.0 million (up 56.54% YoY), and the FY2025 full-year result was -$110.0 million, down 49.37% from the prior year.
- Enterprise Value slipped to -$120.0 million in Q1 2026, from -$110.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$73.7 million in Q4 2024 to a low of -$276.1 million in Q1 2025.
- A 3-year average of -$175.1 million and a median of -$166.7 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value slumped 49.37% in 2025 and soared 56.54% in 2026, its largest moves.
- Tracing AARD's Enterprise Value over 3 years: stood at -$73.7 million in 2024, then tumbled by 49.37% to -$110.0 million in 2025, then decreased by 9.03% to -$120.0 million in 2026.
- Business Quant data shows AARD's Enterprise Value at -$120.0 million in Q1 2026, -$110.0 million in Q4 2025, and -$213.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | -119.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119.96 Mn |
| Dec 31, 2025 | -110.03 Mn |
| Sep 30, 2025 | -213.47 Mn |
| Jun 30, 2025 | -257.62 Mn |
| Mar 31, 2025 | -276.06 Mn |
| Dec 31, 2024 | -73.66 Mn |